Not checkedNot checked for notices yet.
Research Advances on Small Molecule Targets for Tumor Immunotherapy
LIU Lie, YUAN Meng, SHI Jian
Zhongliu Fangzhi Yanjiu · 2019
doi:10.3971/j.issn.1000-8578.2019.19.0094 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
After decades of unremitting efforts, tumor immunotherapy has made significant progress. For patients with advanced cancer, significant clinical benefit has been achieved by blocking the T-cell immune checkpoint PD-1 or CTLA-4 receptor, significantly extending patients' survival. However, in the unselected population, the overall efficiency is still less than 20%, so it is necessary to explore new immunotherapeutics and treatment models. Small molecule-based immunotherapeutic methods have significant advantages in pharmacokinetics and drug utility, showing potential in early studies. This article will review the current status of small-molecule immunotherapy for tumors, in order to find more precise targets for immunotherapy.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.